| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |